HUDSON, N.H., June 6, 2012 /PRNewswire/ -- Atrium Medical's ClearWay local therapeutic infusion catheter has been selected as one of this year's twenty medical innovations by clinicians and other members of the Premier healthcare alliance, a hospital-owned performance improvement alliance of more than 2,600 hospitals and 84,000 other care sites.
Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, showcased the ClearWay before thousands of healthcare representatives at Premier's fourth annual Innovation Celebration. This yearly conference recognizes advancements in healthcare, highlighting industry suppliers committed to innovation and improved patient outcomes.
Selection criteria included the uniqueness of the product, its ability to have an impact on an unmet medical need and its potential to positively impact patient care.
Innovations were shared during Premier's 2012 Breakthroughs Conference and Exhibition in Nashville, Tenn. on June 5. Approximately 4,000 healthcare providers and experts attended the conference.
Atrium's ClearWay local therapeutic infusion catheter is a new atraumatic drug delivery balloon. The ClearWay catheter provides super selective, local intra-vessel infusion of medication, allowing more medication to act locally at a higher concentration and for a longer period of time to maximize its therapeutic effect on the occluding blood clot or diseased vessel. The balloon controllably engages the vessel wall to gently and atraumatically occlude blood flow during drug infusion thus providing drug concentrations hundreds of times greater at the site of local delivery than traditional systemic drug administration. ClearWay offers physicians a simple and highly effective method to maximize drug availability, concentration, and residence time in order to greatly enhance the desired therapeutic effect. ClearWay is available in both rapid exchange (RX) and over the wire (OTW) platforms and is available in balloon diameter ranges of 1.0 mm to 8.0 mm and balloon lengths ranging from 10 mm to 50 mm.
"All of us at Atrium Medical take extraordinary pride in the innovative design and manufacture of our products and the quality service we provide to improve the level of patient care to all of our Premier members," said Michael DuPont, Vice President of Marketing, Atrium Medical Corporation.
"Those who attend and participate in the Innovation Celebration share Premier's commitment to providing innovative, valuable products to our members that impact healthcare's safety, quality and cost," said Durral Gilbert, senior vice president, Supply Chain Emerging Services, Premier. "These new innovations will truly benefit people across the nation as healthcare providers continue to improve care."
About the Premier healthcare alliance, Malcolm Baldrige National Quality Award recipient
Premier is a performance improvement alliance of more than 2,600 U.S. hospitals and 84,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington. http://www.premierinc.com. Stay connected with Premier on Facebook, Twitter and YouTube.
About Atrium Medical Corporation
Atrium Medical Corporation's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Maintaining a commitment to the latest ISO13485 Quality Standards, state-of-the-art manufacturing and automation, cell biology and biomaterial discovery programs, Atrium continues to excel in those healthcare segments that require more advanced surgical intervention for improvements in patient outcomes. Atrium is a business unit of MAQUET Cardiovascular, a member of the GETINGE GROUP of companies. For more information please visit www.atriummed.com.
As a trusted partner for hospitals and clinicians since 1838, MAQUET is a global leader in medical systems that advance surgical interventions, cardiovascular procedures and critical care. MAQUET develops and designs innovative products and therapeutic applications for the operating room, hybrid OR/cath lab, intensive care unit and patient transport within acute care hospitals, improving outcomes and quality of life for patients.
Cardiovascular specialties include intra-aortic balloon counterpulsation (IABC) therapy for cardiac assist; coronary artery bypass surgery; aortic and peripheral vascular surgery; and extracorporeal circulation.
The Critical Care portfolio includes market-leading intensive care ventilators and anesthesia machines.
MAQUET also equips Surgical Workplaces with critical infrastructure such as flexible room design for OR and ICU; OR tables; lights and ceiling supply units; and OR integration for image data management.
MAQUET is a subsidiary of the publicly listed Swedish GETINGE GROUP. In 2011, MAQUET generated nearly 1.4 billion Euro which is more than half of the Group's annual revenue of 2.4 billion Euros. The GETINGE Group has 13,000 employees worldwide, including around 6,000 MAQUET employees in 50 international sales and service organizations, as well as a network of more than 280 sales representatives. For more information please visit www.maquet.com and www.getingegroup.com.
SOURCE Atrium Medical Corporation